Cassava Sciences Inc (SAVA)
22.05
-0.40
(-1.78%)
USD |
NASDAQ |
May 31, 16:00
22.04
-0.01
(-0.05%)
After-Hours: 20:00
Cassava Sciences Price to Book Value: 13.46 for May 31, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 13.46 |
| May 30, 2024 | 13.70 |
| May 29, 2024 | 12.99 |
| May 28, 2024 | 13.23 |
| May 24, 2024 | 13.26 |
| May 23, 2024 | 13.31 |
| May 22, 2024 | 13.50 |
| May 21, 2024 | 13.59 |
| May 20, 2024 | 13.49 |
| May 17, 2024 | 14.11 |
| May 16, 2024 | 13.16 |
| May 15, 2024 | 14.05 |
| May 14, 2024 | 14.24 |
| May 13, 2024 | 12.59 |
| May 10, 2024 | 12.35 |
| May 09, 2024 | 12.89 |
| May 08, 2024 | 13.17 |
| May 07, 2024 | 12.01 |
| May 06, 2024 | 11.84 |
| May 03, 2024 | 12.13 |
| May 02, 2024 | 12.14 |
| May 01, 2024 | 12.18 |
| April 30, 2024 | 12.19 |
| April 29, 2024 | 12.27 |
| April 26, 2024 | 12.29 |
| Date | Value |
|---|---|
| April 25, 2024 | 11.96 |
| April 24, 2024 | 11.41 |
| April 23, 2024 | 11.31 |
| April 22, 2024 | 11.28 |
| April 19, 2024 | 10.81 |
| April 18, 2024 | 11.66 |
| April 17, 2024 | 11.70 |
| April 16, 2024 | 11.57 |
| April 15, 2024 | 11.01 |
| April 12, 2024 | 12.52 |
| April 11, 2024 | 14.37 |
| April 10, 2024 | 13.49 |
| April 09, 2024 | 13.98 |
| April 08, 2024 | 12.97 |
| April 05, 2024 | 11.73 |
| April 04, 2024 | 11.27 |
| April 03, 2024 | 11.32 |
| April 02, 2024 | 10.85 |
| April 01, 2024 | 11.16 |
| March 28, 2024 | 6.383 |
| March 27, 2024 | 6.424 |
| March 26, 2024 | 6.200 |
| March 25, 2024 | 6.197 |
| March 22, 2024 | 6.232 |
| March 21, 2024 | 6.663 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9852
Minimum
Jun 05 2019
33.61
Maximum
Feb 03 2021
6.638
Average
5.855
Median
May 04 2021
Price to Book Value Benchmarks
| Amylyx Pharmaceuticals Inc | 0.3605 |
| ACADIA Pharmaceuticals Inc | 5.369 |
| Vertex Pharmaceuticals Inc | 6.336 |
| Cormedix Inc | 4.993 |
| Oragenics Inc | 8.766 |
Price to Book Value Related Metrics
| PS Ratio | 22.80 |
| Price | 22.05 |
| Earnings Yield | -9.84% |
| Market Cap | 1.058B |
| Operating PE Ratio | 29.89 |
| Normalized PE Ratio | 4.632 |